KPC Pharmaceuticals Inc (600422) — Capital Reinvestment Ratio
KPC Pharmaceuticals Inc (600422) has a Capital Reinvestment Ratio of 0.29x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥113.07 Million) in capital expenditures (CN¥32.53 Million). Check 600422 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
KPC Pharmaceuticals Inc Capital Reinvestment Ratio (1999–2025)
This chart tracks KPC Pharmaceuticals Inc's Capital Reinvestment Ratio across 25 annual periods. For the full cash flow conversion analysis, see 600422 cash flow conversion.
Annual Capital Reinvestment Ratio for KPC Pharmaceuticals Inc (1999–2025)
Year-by-year Capital Reinvestment Ratio for KPC Pharmaceuticals Inc from 1999 to 2025. See KPC Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CN¥289.24 Million | CN¥90.56 Million | ▲ +218.5% |
| 2024 | 0.10x | CN¥808.07 Million | CN¥79.43 Million | ▼ -32.4% |
| 2023 | 0.15x | CN¥754.33 Million | CN¥109.64 Million | ▼ -63.7% |
| 2022 | 0.40x | CN¥253.90 Million | CN¥101.75 Million | ▼ -57.3% |
| 2021 | 0.94x | CN¥251.63 Million | CN¥236.17 Million | ▲ +142.4% |
| 2020 | 0.39x | CN¥409.94 Million | CN¥158.73 Million | ▼ -52.1% |
| 2019 | 0.81x | CN¥429.50 Million | CN¥347.35 Million | ▲ +31.1% |
| 2018 | 0.62x | CN¥352.07 Million | CN¥217.26 Million | ▼ -44.3% |
| 2017 | 1.11x | CN¥242.53 Million | CN¥268.74 Million | ▲ +69.5% |
| 2016 | 0.65x | CN¥311.16 Million | CN¥203.45 Million | ▲ +47.8% |
| 2015 | 0.44x | CN¥476.62 Million | CN¥210.82 Million | ▼ -24.8% |
| 2014 | 0.59x | CN¥379.13 Million | CN¥222.98 Million | ▼ -33.1% |
| 2013 | 0.88x | CN¥241.97 Million | CN¥212.65 Million | ▲ +52.2% |
| 2012 | 0.58x | CN¥213.33 Million | CN¥123.22 Million | ▲ +89.0% |
| 2011 | 0.31x | CN¥140.24 Million | CN¥42.85 Million | ▼ -56.7% |
| 2010 | 0.71x | CN¥90.82 Million | CN¥64.16 Million | ▲ +382.6% |
| 2009 | 0.15x | CN¥128.57 Million | CN¥18.82 Million | ▲ +2.4% |
| 2008 | 0.14x | CN¥91.59 Million | CN¥13.09 Million | ▲ +11.5% |
| 2007 | 0.13x | CN¥130.06 Million | CN¥16.67 Million | ▼ -73.0% |
| 2006 | 0.47x | CN¥61.25 Million | CN¥29.03 Million | ▼ -9.5% |
| 2003 | 0.52x | CN¥61.23 Million | CN¥32.08 Million | ▼ -88.6% |
| 2002 | 4.58x | CN¥17.38 Million | CN¥79.62 Million | ▲ +1594.6% |
| 2001 | 0.27x | CN¥67.07 Million | CN¥18.13 Million | ▼ -46.7% |
| 2000 | 0.51x | CN¥47.76 Million | CN¥24.20 Million | ▲ +141.1% |
| 1999 | 0.21x | CN¥60.24 Million | CN¥12.67 Million | — |